TcdB From Hypervirulent Clostridioides difficile Induces Neuronal Loss and Neurotransmitter Alterations in the Intrinsic Enteric Nervous System - Scorecard - MDSpire
Advertisement
TcdB From Hypervirulent Clostridioides difficile Induces Neuronal Loss and Neurotransmitter Alterations in the Intrinsic Enteric Nervous System
Clinical Scorecard: Impact of TcdB from Hypervirulent Clostridioides difficile on Neuronal Integrity and Neurotransmitter Dynamics in the Enteric Nervous System
At a Glance
Category
Detail
Condition
Clostridioides difficile infection (CDI)
Key Mechanisms
TcdB2 toxin induces dose-dependent cytopathic effects on enteric neurons, causing neuronal loss and altering neurotransmitter composition via TFPI receptor-mediated entry and glucosylation of small GTPases
Target Population
Patients with CDI, particularly infections caused by hypervirulent C. difficile strains expressing TcdB2
Care Setting
Hospital and research settings focused on intestinal infections and neurogastroenterology
Key Highlights
TcdB2 from hypervirulent C. difficile directly damages intrinsic enteric neurons in the colonic wall both in vitro and in vivo.
Neuronal loss is accompanied by increased expression of choline acetyltransferase (ChAT) and neural nitric oxide synthase (nNOS) prior to cytopathic changes.
TcdB2 effects are mediated through the tissue factor pathway inhibitor (TFPI) receptor, highlighting a novel mechanism of ENS involvement in CDI.
Guideline-Based Recommendations
Diagnosis
Consider CDI diagnosis in patients with intestinal infections, especially with hypervirulent strains producing TcdB2.
Recognize potential ENS involvement in CDI pathogenesis beyond epithelial damage.
Management
Target therapies to neutralize TcdB toxin effects may help preserve enteric neuronal integrity.
Monitor and manage intestinal motility and secretion disturbances potentially arising from ENS neuronal loss.
Monitoring & Follow-up
Assess ENS function and neurotransmitter alterations in CDI patients to evaluate disease progression and response to treatment.
Monitor for signs of neurogenic inflammation and enteric neuronal damage during CDI.
Risks
Neuronal loss in the ENS may contribute to long-term intestinal dysfunction post-CDI.
Hypervirulent C. difficile strains expressing TcdB2 pose increased risk for severe ENS damage.
Patient & Prescribing Data
Patients infected with hypervirulent C. difficile strains producing TcdB2
No direct prescribing data provided; findings support development of targeted therapies against TcdB2 to protect ENS neurons and maintain neurotransmitter balance.
Clinical Best Practices
Recognize the role of TcdB2 in ENS neuronal damage during CDI to inform comprehensive patient management.
Incorporate strategies to mitigate neurogenic inflammation and preserve ENS function in CDI treatment protocols.
Utilize animal and in vitro models to further investigate ENS-targeted interventions in CDI.
